AT13387 in Adults With Refractory Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Solid Tumors|Breast Cancer
Interventions: DRUG: AT13387
Sponsor: National Cancer Institute (NCI)